Lower Respiratory Tract Therapeutics Global Market Report 2024

Description

The lower respiratory tract constitutes the segment of the respiratory system responsible for the exchange of gases, wherein oxygen is taken in, and carbon dioxide is expelled. Lower respiratory tract therapeutics is a specialized field within medical science and clinical practice that is dedicated to the diagnosis, treatment, and management of diseases and disorders affecting the lower respiratory tract. These therapeutic interventions aim to enhance the quality of life and overall health outcomes for individuals grappling with lower respiratory tract disorders.

The primary disease types addressed by lower respiratory tract therapeutics include asthma, chronic obstructive pulmonary disease (COPD), pneumonia, tuberculosis, bronchitis, and others. Asthma, for instance, is a chronic respiratory disorder characterized by inflammation of the airways, resulting in their narrowing and leading to frequent bouts of coughing, wheezing, chest tightness, and shortness of breath. Various drug classes are employed in lower respiratory tract therapeutics, including antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), cough suppressants, nasal decongestants, and others. These therapeutics are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, providing individuals with access to the necessary medications for managing lower respiratory tract conditions.

The lower respiratory tract therapeutics market research report is one of a series of new reports from The Business Research Company that provides lower respiratory tract therapeutics market statistics, including lower respiratory tract therapeutics industry global market size, regional shares, competitors with lower respiratory tract therapeutics market share, detailed lower respiratory tract therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the lower respiratory tract therapeutics industry. This lower respiratory tract therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lower respiratory tract therapeutics market size has grown strongly in recent years. It will grow from $32.91 billion in 2023 to $35.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth observed in the historical period in lower respiratory tract therapeutics can be attributed to several factors. These include significant discoveries in antibiotics, the implementation of vaccination programs, campaigns promoting smoking cessation, advancements in inhalation therapy, and the overall growth of healthcare infrastructure. These factors collectively contributed to improved prevention, diagnosis, and treatment of lower respiratory tract disorders during the specified historical timeframe.

The lower respiratory tract therapeutics market size is expected to see strong growth in the next few years. It will grow to $48.37 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth in the forecast period for lower respiratory tract therapeutics can be attributed to several factors. These include the escalation of air pollution levels, an aging population leading to increased respiratory issues, the challenge of antimicrobial resistance, and the impact of various environmental factors. Key trends expected during this period encompass the adoption of precision medicine approaches, ongoing technological innovations in the field, the emergence of biologic therapies, the integration of telehealth in respiratory care, and the development of personalized inhalation devices. These trends collectively reflect the evolving landscape of lower respiratory tract therapeutics, driven by advancements in healthcare and a focus on personalized and innovative treatment approaches.

The escalating occurrence of respiratory ailments is poised to significantly bolster the lower respiratory tract therapeutics market in the forthcoming period. Respiratory illnesses encompass a range of medical conditions impacting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Lower respiratory tract therapeutics play a pivotal role in the early identification and diagnosis of these conditions, enabling timely intervention and management. This proactive approach aids in halting disease progression, controlling the spread of infectious respiratory diseases, and mitigating the likelihood of complications. As per data reported in September 2022 by the NCD Alliance, a civil society organization based in Switzerland, lung cancer stood as the leading cause of global cancer-related deaths, foreseeing an annual estimate of 2.2 million new cases and 1.8 million fatalities. Furthermore, chronic respiratory disorders impacted 550 million adults worldwide, resulting in 4.2 million deaths, constituting 7% of all mortalities. Thus, the escalating prevalence of respiratory diseases is set to act as a major impetus driving the growth of the lower respiratory tract therapeutics market.

The increasing prevalence of smoking is anticipated to be a key driving force behind the growth trajectory of the lower respiratory tract therapeutics market. Smoking denotes the inhalation and exhalation of smoke derived from burning tobacco or other substances. Lower respiratory tract therapeutics are instrumental in mitigating inflammation, alleviating symptoms, slowing down disease progression, enhancing airflow and lung function, reducing exacerbation frequency and severity, improving oxygenation, and augmenting the prospects of successful smoking cessation. For instance, a report from The World Health Organization, an intergovernmental organization headquartered in Switzerland, revealed that over 8 million individuals succumb to tobacco-related causes annually, including 1.3 million non-smokers exposed to second-hand smoke. Consequently, the mounting prevalence of smoking is emerging as a significant factor fueling the expansion of the lower respiratory tract therapeutics market.

Advancements in product innovations stand out as a prominent trend within the lower respiratory tract therapeutics market. Major players in this domain are actively introducing novel products to fortify their positions in the market. For instance, in 2022, AstraZeneca plc, a pharmaceutical and biotechnology company based in the UK, collaborated with Sanofi S.A., a French pharmaceutical company, to introduce Beyfortus. This medication received approval from the European Union (E.U.) as a preventive measure against respiratory syncytial virus (RSV) and lower respiratory tract illnesses in newborns and infants during their initial RSV season. Markedly, Beyfortus represents the first single-dose RSV passive vaccination targeting the general newborn population, encompassing healthy infants, full-term or preterm babies, and those with specific medical conditions.

Major players operating in the lower respiratory tract therapeutics market are concentrating on innovative offerings such as triple combination drugs tailored for COPD management to bolster their market revenues. This triple combination therapy for COPD comprises long-acting muscarinic antagonists (LAMA), long-acting beta-agonists (LABA), and inhaled corticosteroids (ICS) as the three primary inhaled medications. For instance, Lupin Limited, a pharmaceutical company based in India, introduced Vilfuro-G in November 2023. Vilfuro-G, available in a fixed dosage strength with once-daily dosing recommendations, is poised to significantly enhance the lives of COPD patients. This launch demonstrates Lupin's commitment to expanding its respiratory product line and providing healthcare professionals and patients with state-of-the-art treatment alternatives. Notably, Vilfuro-G stands as the only fixed-dose combination specifically formulated to combine glycopyrronium bromide, vilanterol, and fluticasone furoate for the long-term treatment and management of moderate to severe COPD.

In June 2022, Pfizer Inc., a prominent US-based pharmaceutical and biotechnology company, successfully acquired ReViral for an undisclosed amount. Through this acquisition, Pfizer seeks to broaden its portfolio of potential treatment options, with a particular focus on sisunatovir. Sisunatovir is an orally administered inhibitor specifically designed to prevent the respiratory syncytial virus (RSV) from attaching to the host cell's membrane. ReViral Ltd., the UK-based biopharmaceutical company that Pfizer acquired, is known for its dedication to developing novel antiviral therapeutics with a focus on targeting respiratory syncytial virus.

Major companies operating in the lower respiratory tract therapeutics market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Grifols S.A., Menarini Group, Chiesi Farmaceutici S.p.A., Cipla Limited, BioMarin Pharmaceutical Inc., Mundipharma International Limited, Orion Corporation, Sunovion Pharmaceuticals Inc., Innoviva Inc., Insmed Incorporated, Vectura Group plc, Kamada Ltd., Theravance Biopharma Inc., Verona Pharma plc, Circassia Pharmaceuticals plc

North America was the largest region in the lower respiratory tract therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lower respiratory tract therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lower respiratory tract therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The lower respiratory tract therapeutics market consists of sales of beta-lactam antibiotics, macrolides, and fluoroquinolones. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lower Respiratory Tract Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lower respiratory tract therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lower respiratory tract therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lower respiratory tract therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Disease Type: Asthma; Chronic obstructive pulmonary disease; Pneumonia; Tuberculosis; Bronchitis; Other Diseases
2) By Drug Class: Antibiotics; Non-Steroidal Anti-Inflammatory Drug; Cough Suppressant; Nasal Decongestant; Other Drug Classes
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r14285

1. Executive Summary

2. Lower Respiratory Tract Therapeutics Market Characteristics

3. Lower Respiratory Tract Therapeutics Market Trends And Strategies

4. Lower Respiratory Tract Therapeutics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Lower Respiratory Tract Therapeutics Market Size and Growth

5.1. Global Lower Respiratory Tract Therapeutics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Lower Respiratory Tract Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Lower Respiratory Tract Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lower Respiratory Tract Therapeutics Market Segmentation

6.1. Global Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Asthma
Chronic obstructive pulmonary disease
Pneumonia
Tuberculosis
Bronchitis
Other Diseases
6.2. Global Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antibiotics
Non-Steroidal Anti-Inflammatory Drug
Cough Suppressant
Nasal Decongestant
Other Drug Classes
6.3. Global Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Lower Respiratory Tract Therapeutics Market Regional And Country Analysis

7.1. Global Lower Respiratory Tract Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Lower Respiratory Tract Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lower Respiratory Tract Therapeutics Market

8.1. Asia-Pacific Lower Respiratory Tract Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lower Respiratory Tract Therapeutics Market

9.1. China Lower Respiratory Tract Therapeutics Market Overview
9.2. China Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lower Respiratory Tract Therapeutics Market

10.1. India Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lower Respiratory Tract Therapeutics Market

11.1. Japan Lower Respiratory Tract Therapeutics Market Overview
11.2. Japan Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lower Respiratory Tract Therapeutics Market

12.1. Australia Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lower Respiratory Tract Therapeutics Market

13.1. Indonesia Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lower Respiratory Tract Therapeutics Market

14.1. South Korea Lower Respiratory Tract Therapeutics Market Overview
14.2. South Korea Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lower Respiratory Tract Therapeutics Market

15.1. Western Europe Lower Respiratory Tract Therapeutics Market Overview
15.2. Western Europe Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lower Respiratory Tract Therapeutics Market

16.1. UK Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lower Respiratory Tract Therapeutics Market

17.1. Germany Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lower Respiratory Tract Therapeutics Market

18.1. France Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lower Respiratory Tract Therapeutics Market

19.1. Italy Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lower Respiratory Tract Therapeutics Market

20.1. Spain Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lower Respiratory Tract Therapeutics Market

21.1. Eastern Europe Lower Respiratory Tract Therapeutics Market Overview
21.2. Eastern Europe Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lower Respiratory Tract Therapeutics Market

22.1. Russia Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lower Respiratory Tract Therapeutics Market

23.1. North America Lower Respiratory Tract Therapeutics Market Overview
23.2. North America Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lower Respiratory Tract Therapeutics Market

24.1. USA Lower Respiratory Tract Therapeutics Market Overview
24.2. USA Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lower Respiratory Tract Therapeutics Market

25.1. Canada Lower Respiratory Tract Therapeutics Market Overview
25.2. Canada Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lower Respiratory Tract Therapeutics Market

26.1. South America Lower Respiratory Tract Therapeutics Market Overview
26.2. South America Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lower Respiratory Tract Therapeutics Market

27.1. Brazil Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lower Respiratory Tract Therapeutics Market

28.1. Middle East Lower Respiratory Tract Therapeutics Market Overview
28.2. Middle East Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lower Respiratory Tract Therapeutics Market

29.1. Africa Lower Respiratory Tract Therapeutics Market Overview
29.2. Africa Lower Respiratory Tract Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Lower Respiratory Tract Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Lower Respiratory Tract Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lower Respiratory Tract Therapeutics Market Competitive Landscape And Company Profiles

30.1. Lower Respiratory Tract Therapeutics Market Competitive Landscape
30.2. Lower Respiratory Tract Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Lower Respiratory Tract Therapeutics Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Sanofi S.A.
31.3. Bristol-Myers Squibb Company
31.4. AstraZeneca PLC
31.5. GlaxoSmithKline plc.
31.6. Eli Lilly and Co Ltd.
31.7. Boehringer Ingelheim International GmbH
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Regeneron Pharmaceuticals Inc.
31.10. Vertex Pharmaceuticals Incorporated
31.11. Grifols S.A.
31.12. Menarini Group
31.13. Chiesi Farmaceutici S.p.A.
31.14. Cipla Limited
31.15. BioMarin Pharmaceutical Inc.

32. Global Lower Respiratory Tract Therapeutics Market Competitive Benchmarking

33. Global Lower Respiratory Tract Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lower Respiratory Tract Therapeutics Market

35. Lower Respiratory Tract Therapeutics Market Future Outlook and Potential Analysis

35.1 Lower Respiratory Tract Therapeutics Market In 2028 - Countries Offering Most New Opportunities
35.2 Lower Respiratory Tract Therapeutics Market In 2028 - Segments Offering Most New Opportunities
35.3 Lower Respiratory Tract Therapeutics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer